Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding Study of BA058 in Postmenopausal Women with Osteoporosis
2007-004779-21Phase 2Completed
- Sponsor
- Radius Health Inc
- Start
- Oct 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of abaloparatide in osteoporosis (2 arms), sponsored by Radius Health Inc. Primary endpoints: Pharmacodynamic effects of BA058 and Safety and tolerability of BA058. Started Oct 2007; status: completed.
02
Drugs
abaloparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2007-004779-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004779-21.